迈瑞医疗董事长完成2亿元增持，提升控股比例彰显长期信心

中金财经2025-12-23

近日，迈瑞医疗(300760.SZ)发布了实际控制人之一、董事长增持计划实施完成的公告。据公告披露，2025年11月27日至2025年12月12日期间，李西廷先生通过集中竞价交易的方式累计增持公司股份1,005,381股，增持股份占公司股份的0.08%，增持金额共计2亿元(含交易费用)。其增持金额已达到可执行最高额，至此李西廷先生本次增持计划已实施完成。　　市场人士分析指出，此次增持顺应了...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2593510464?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-23 14:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593510464","market":"hk","top_or_hot":-1,"title":"迈瑞医疗董事长完成2亿元增持，提升控股比例彰显长期信心","media":"中金财经","content":"<div>\n<p>近日，迈瑞医疗(300760.SZ)发布了实际控制人之一、董事长增持计划实施完成的公告。据公告披露，2025年11月27日至2025年12月12日期间，李西廷先生通过集中竞价交易的方式累计增持公司股份1,005,381股，增持股份占公司股份的0.08%，增持金额共计2亿元(含交易费用)。其增持金额已达到可执行最高额，至此李西廷先生本次增持计划已实施完成。\r\n\r\n　　市场人士分析指出，此次增持顺应了...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushizhibo/20251223/31884475.shtml\">网页链接</a>\n\n</div>\n","source":"zhongjincaijing_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>迈瑞医疗董事长完成2亿元增持，提升控股比例彰显长期信心</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n迈瑞医疗董事长完成2亿元增持，提升控股比例彰显长期信心\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-23 14:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://sc.stock.cnfol.com/gushizhibo/20251223/31884475.shtml><strong>中金财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，迈瑞医疗(300760.SZ)发布了实际控制人之一、董事长增持计划实施完成的公告。据公告披露，2025年11月27日至2025年12月12日期间，李西廷先生通过集中竞价交易的方式累计增持公司股份1,005,381股，增持股份占公司股份的0.08%，增持金额共计2亿元(含交易费用)。其增持金额已达到可执行最高额，至此李西廷先生本次增持计划已实施完成。\r\n\r\n　　市场人士分析指出，此次增持顺应了...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushizhibo/20251223/31884475.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2213484517.USD","symbol_name":"FRANKLIN TEMPLETON CHINA A-SHARES \"A\" (USD) ACC","start_time":0,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251223/31884475.shtml","article_id":"2593510464","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2593510464","pubTimestamp":1766471822,"columns":[],"sourceInfo":{"source_id":"zhongjincaijing_highlight","name":"中金在线"},"weMediaInfo":null,"summary":"近日，迈瑞医疗发布了实际控制人之一、董事长增持计划实施完成的公告。据公告披露，2025年11月27日至2025年12月12日期间，李西廷先生通过集中竞价交易的方式累计增持公司股份1,005,381股，增持股份占公司股份的0.08%，增持金额共计2亿元。其增持金额已达到可执行最高额，至此李西廷先生本次增持计划已实施完成。","collect":0,"end_time":0,"defaultTopTitle":"cnfol.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300760":"迈瑞医疗","LU2213484517.USD":"FRANKLIN TEMPLETON CHINA A-SHARES \"A\" (USD) ACC","LU2348773727.SGD":"Aberdeen Standard SICAV I - Asian Sustainable Development Equity A Acc SGD-H","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU2424517915.HKD":"abrdn SICAV I -  ASIAN SDG EQUITY \"A\" (HKD) ACC","LU0823426480.USD":"法巴中国股票经典Dis","LU0823426308.USD":"法巴中国股票基金","IE00B29SXG58.USD":"FSSA CHINA FOCUS \"I\" (USD) ACC","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","IE00B031J352.USD":"FSSA GREATER CHINA GROWTH \"I\" (USD) INC","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","LU0359201612.USD":"贝莱德中国基金A2","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0594300419.USD":"富达中国消费基金A","BK0251":"专用设备","LU1997245177.USD":"安联神洲A股基金","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","IE0008368742.USD":"首域中国增长基金I Acc","LU1688375341.USD":"贝莱德中国灵活股票基金","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU1720050803.USD":"安联全方位中国股票基金","LU0605514214.HKD":"FIDELITY CHINA CONSUMER \"A\" (HKD) ACC","LU2153592121.USD":"Aberdeen Standard SICAV I - Emerging Markets Sustainable Development Equity A Acc USD","LU0650527681.SGD":"Fidelity China Consumer A-SGD","IE00B031HY20.USD":"FSSA CHINA GROWTH \"I\" (USD) INC","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","LU0594300179.USD":"FIDELITY CHINA CONSUMER \"A\" (USD) ACC","LU2153591404.USD":"Aberdeen Standard SICAV I - Asian Sustainable Development Equity A Acc USD","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","IE0005HP3H50.USD":"GUINNESS CHINA \"C\" (USD) ACC","LU1734074674.USD":"NINETY ONE GSF ASIA PACIFIC FRANCHISE \"A\"(USD) ACC","LU0084288322.USD":"Natixis Asia Equity RD USD","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU2348774022.SGD":"Aberdeen Standard SICAV I - Emerging Markets Sustainable Development Equity A Acc SGD-H","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","IE0031814852.USD":"FSSA GREATER CHINA GROWTH \"I\" (USD) ACC","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","LU1146622755.USD":"安本中国A股股票基金A Acc","SGXZ49509284.SGD":"United China A Shares Innovation A Acc SGD","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC"},"translate_title":"The chairman of Mindray Medical completed a 200 million yuan increase in holdings, increasing the holding ratio to demonstrate long-term confidence","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300760":1.5},"content_text":"近日，迈瑞医疗(300760.SZ)发布了实际控制人之一、董事长增持计划实施完成的公告。据公告披露，2025年11月27日至2025年12月12日期间，李西廷先生通过集中竞价交易的方式累计增持公司股份1,005,381股，增持股份占公司股份的0.08%，增持金额共计2亿元(含交易费用)。其增持金额已达到可执行最高额，至此李西廷先生本次增持计划已实施完成。\r\n\r\n　　市场人士分析指出，此次增持顺应了当前政策层面推动资本市场健康、稳定发展的引导方向，更体现了李西廷先生对公司内在价值的深度认可以及未来持续发展的坚实信心。而且大额增持计划在短期内实施完成，也进一步凸显了实际控制人对公司长期价值的坚定看好。\r\n\r\n　　不仅如此，此次增持行动也与公司稳健向好的基本面形成了呼应。从经营端来看，迈瑞医疗产品线上不断推出创新型号，并加速在海外新兴市场的本土化布局，整体保持稳健提升态势。更重要的是，公司技术创新与市场拓展的双轮驱动能力为其可持续发展提供了坚实支撑，也让市场进一步关注到了其长期价值。\r\n\r\n　　另据公告披露，待本次增持计划实施完成后，李西廷先生直接持有公司股份1,005,381股，增持后李西廷先生及其一致行动人合计控制公司股份625,028,716股，占公司股份的51.55%。有机构分析指出，作为国产医疗器械龙头，通过自主研发和技术创新，迈瑞医疗的核心竞争力及盈利能力不断强化，全球市场份额有望持续提升。预计未来在医疗新基建及全球化趋势下，公司将持续受益于行业机遇，实现长期价值增长。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2593510464","isCrawlerRequest":true}